David Michael Williams - Aug 3, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Signature
/s/ Jon Filderman as Attorney-in-Fact for David Michael Williams
Stock symbol
MRK
Transactions as of
Aug 3, 2022
Transactions value $
$0
Form type
4
Date filed
8/4/2022, 03:59 PM
Previous filing
May 4, 2022
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 9.26K Aug 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +17.1K $0.00 17.1K Aug 3, 2022 Common Stock 17.1K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025.